Cronos Group Inc. (NASDAQ:CRON – Get Free Report) was the recipient of a significant drop in short interest during the month of December. As of December 31st, there was short interest totalling 3,290,000 shares, a drop of 10.6% from the December 15th total of 3,680,000 shares. Based on an average daily volume of 1,210,000 shares, the days-to-cover ratio is currently 2.7 days. Approximately 1.6% of the company’s shares are short sold.
Cronos Group Stock Up 1.0 %
Cronos Group stock traded up $0.02 during trading hours on Friday, hitting $1.99. The stock had a trading volume of 1,401,703 shares, compared to its average volume of 1,270,717. The stock has a market cap of $760.78 million, a price-to-earnings ratio of -15.31, a P/E/G ratio of 1.78 and a beta of 0.97. Cronos Group has a one year low of $1.86 and a one year high of $3.14. The business’s 50 day simple moving average is $2.02 and its 200-day simple moving average is $2.17.
Institutional Investors Weigh In On Cronos Group
Large investors have recently added to or reduced their stakes in the business. Mackenzie Financial Corp acquired a new stake in Cronos Group in the second quarter valued at approximately $3,237,000. Barclays PLC acquired a new stake in Cronos Group in the third quarter valued at approximately $97,000. International Assets Investment Management LLC grew its stake in Cronos Group by 119.0% in the third quarter. International Assets Investment Management LLC now owns 41,643 shares of the company’s stock valued at $91,000 after acquiring an additional 22,628 shares during the period. Renaissance Technologies LLC grew its stake in Cronos Group by 37.9% in the second quarter. Renaissance Technologies LLC now owns 464,949 shares of the company’s stock valued at $1,083,000 after acquiring an additional 127,753 shares during the period. Finally, SeaCrest Wealth Management LLC grew its stake in Cronos Group by 77.3% in the fourth quarter. SeaCrest Wealth Management LLC now owns 189,245 shares of the company’s stock valued at $382,000 after acquiring an additional 82,500 shares during the period. Institutional investors and hedge funds own 8.71% of the company’s stock.
Cronos Group Company Profile
Cronos Group Inc operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands.
See Also
- Five stocks we like better than Cronos Group
- Business Services Stocks Investing
- Earn High Dividends With 2 Top REITs Set to Perform in 2025
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Oilfield Leader SLB: An AI Name You Need to Know
- Profitably Trade Stocks at 52-Week Highs
- Top ETFs That Beat the Market in 2024 and Could Do It Again
Receive News & Ratings for Cronos Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cronos Group and related companies with MarketBeat.com's FREE daily email newsletter.